Aveo Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 6.66, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Aveo Pharmaceuticals Inc 's Accounts Receivable average collection period in the Sep 30 2022 quarter, has increased to 55 days, from 53 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 273 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2022 from 1094 to 2126.

What is Receivable Turnover Ratio?
What is Aveo Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AVEO Receivables Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Receivable Change	125.42 %	262.06 %	1031.38 %	719.63 %	689.26 %
Y / Y Revenue Change	100.68 %	234.89 %	989.58 %	1914.11 %	321.47 %
Receivable Turnover Ratio (TTM)	6.66	6.84	6.97	7.24	6.87
AVEO's Total Ranking	# 2126	# 1094	# 1094	# 1092	# 1739
Accounts Receivable average collection period days	55	53	52	50	53
Seq. Receivable Change	22.5 %	18.05 %	31.92 %	18.16 %	96.75 %
Seq. Revenue Change	20.33 %	20.96 %	17.23 %	17.61 %	100.81 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 95
Healthcare Sector	# 274
Overall Market	# 2126

Receivable Turnover Ratio Statistics
High	Average	Low
19.51	7.04	0.19
(Dec 31 2019)		(Dec. 30, 2013)

AVEO Company Profile • Back to AVEO Efficiency Comparisons • Compare AVEO Receivables Turnover Ratio to its Competitors

Financial Statements
Aveo Pharmaceuticals Inc 's Accounts Receivable	$ 19 Millions	Visit AVEO's Balance sheet
Aveo Pharmaceuticals Inc 's Sales TTM	$ 95 Millions	Visit AVEO's Income Statement
Sources of AVEO's Revenues		Visit AVEO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVEO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVEO's Growth Rates	AVEO's Roa	AVEO's Inventory Turnover Ratio	AVEO's Dividend Comparisons
AVEO's Profitability Ratios	AVEO's Roi	AVEO's Asset Turnover Ratio	AVEO's Dividend Growth
AVEO's Valuation Ratios	AVEO's Roe	AVEO's Financial Strength Ratios	AVEO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2022	Receivable at quarter ending Sep 30 2022
The Oncology Institute Inc	13.74	$ 384.062 Millions	$ 27.946 Millions
Cano Health Inc	13.56	$ 2,468.011 Millions	$ 182.046 Millions
Kiniksa Pharmaceuticals International Plc	13.52	$ 177.041 Millions	$ 13.098 Millions
Sonendo Inc	13.31	$ 39.317 Millions	$ 2.954 Millions
Emmaus Life Sciences Inc	13.16	$ 15.480 Millions	$ 1.176 Millions
Nurix Therapeutics Inc	13.08	$ 39.240 Millions	$ 3.000 Millions
Adc Therapeutics Sa	13.05	$ 174.027 Millions	$ 13.339 Millions
Thorne Healthtech Inc	12.56	$ 121.146 Millions	$ 9.646 Millions
Myovant Sciences Ltd	12.33	$ 333.323 Millions	$ 27.037 Millions
Marker Therapeutics inc	12.02	$ 6.946 Millions	$ 0.578 Millions
Chinook Therapeutics Inc	11.94	$ 56.852 Millions	$ 4.761 Millions
Semler Scientific inc	11.93	$ 54.433 Millions	$ 4.563 Millions
Abiomed Inc	11.77	$ 1,074.096 Millions	$ 91.284 Millions
Agenus Inc	11.74	$ 89.901 Millions	$ 7.655 Millions
Embecta Corp	11.71	$ 1,129.500 Millions	$ 96.450 Millions
Lifeloc Technologies Inc	11.62	$ 8.000 Millions	$ 0.689 Millions
Cidara Therapeutics Inc	11.42	$ 68.530 Millions	$ 6.004 Millions
Petvivo Holdings Inc	11.37	$ 0.388 Millions	$ 0.034 Millions
Longeveron Inc	11.29	$ 1.310 Millions	$ 0.116 Millions
Avita Medical Inc	11.20	$ 31.986 Millions	$ 2.856 Millions
Procyon Corporation	11.16	$ 4.828 Millions	$ 0.433 Millions
National Healthcare Corp	11.11	$ 1,104.619 Millions	$ 99.436 Millions
Icu Medical Inc	11.07	$ 2,042.508 Millions	$ 184.440 Millions
Integrated Biopharma Inc	11.03	$ 55.821 Millions	$ 5.059 Millions
Ultragenyx Pharmaceutical Inc	10.97	$ 343.370 Millions	$ 31.293 Millions
Cadre Holdings inc	10.90	$ 437.729 Millions	$ 40.156 Millions
Option Care Health Inc	10.74	$ 3,844.716 Millions	$ 357.872 Millions
International Stem Cell Corporation	10.71	$ 7.593 Millions	$ 0.709 Millions
Nascent Biotech Inc	10.67	$ 2.000 Millions	$ 0.188 Millions
Strata Skin Sciences Inc	10.61	$ 34.616 Millions	$ 3.262 Millions

Date modified: 2026-08-29T17:23:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.